Journal of Advances in Biology & Biotechnology

The present research investigated Ludwigia adscendens crude methanol extract invitro anticancer anthelminthic, and invivo anti-nociceptive, antidiabetic and toxicological properties. The coarsely dried plant powder was extracted using methanol. The methanolic extract (MELA) was further tested for anticancer, anthelminthic, anti-nociceptive, antidiabetic and toxicological activities. Cell Viability Assay was used for anticancer testing, and the earthworm assay was used for anthelminthic testing using different concentrations. Antinociceptive tests were done on Swiss albino mice at 200 and 400 mg/kg utilizing a hot plate, acetic acid induced writhing & formalin-induced paw licking tests. Antidiabetic test was done using Blood Glucose Determination test using the dose of 150 mg/kg and 300 mg/kg. Acute toxicity was tested utilizing cinnamon oil-induced toxicological tests at 3000, 5000 and 7000 mg/kg. The MELA demonstrated 39.16% inhibition at 1000µg/mL in the Cell Viability Assay. The earthworm died after 6 minutes and 4 seconds in the 100 mg/mL anthelminthic test, whereas Albendazole killed it in 4 minutes and 20 seconds. Hot plate test results were substantial. The formalin-induced nociception test demonstrated strong inhibition rates of 79.54% in the early phase and 74.54% in the late phase at 400 mg/kg, compared to 62.99% and 68.18% for diclofenac sodium. Acetic acid-induced writhing test showed 77.66% of pain inhibition where’s Diclofenac sodium showed 79.61%. MELA inhibited blood glucose level very significantly compared to the standard Glibenclamide. In toxicological testing, 7000 mg/kg killed mice 2/5, whereas cinnamon oil killed 5/5 within 24 hours. The study shows that MELA has moderate anticancer, significant anthelmintic, anti-nociceptive, antidiabetic and mild toxicological properties. They may support the plant's use in conventional medicine to relieve pain, minimize drug intoxication, and prevent cancer, control diabetes and parasitic disorders.